La evaluación precoz de Nirsevimab utilizando datos del mundo real confirman los hallazgos de los ensayos clínicos
Ares-Gómez S, Mallah N, Santiago-Pérez M et al. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study. Lancet Infect Dis published April 30, 2024 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00215-9/abstract#:~:text=In%20the%20catch%2Dup%20and%20seasonal%20groups%20combined%2C%2030%20(,6%E2%80%9390%C2%B72). Resultados del estudio poblacional prospectivo NIRSE-GAL llevado a cabo en la temporada de…
